» Articles » PMID: 30275950

Protein Interaction and Functional Data Indicate MTHFD2 Involvement in RNA Processing and Translation

Overview
Journal Cancer Metab
Publisher Biomed Central
Specialty Oncology
Date 2018 Oct 3
PMID 30275950
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The folate-coupled metabolic enzyme MTHFD2 is overexpressed in many tumor types and required for cancer cell proliferation, and is therefore of interest as a potential cancer therapeutic target. However, recent evidence suggests that MTHFD2 has a non-enzymatic function which may underlie the dependence of cancer cells on this protein. Understanding this non-enzymatic function is important for optimal targeting of MTHFD2 in cancer.

Methods: To identify potential non-enzymatic functions of MTHFD2, we defined its interacting proteins using co-immunoprecipitation and mass spectrometry and integrated this information with large-scale co-expression analysis, protein dynamics, and gene expression response to MTHFD2 knockdown.

Results: We found that MTHFD2 physically interacts with a set of nuclear proteins involved in RNA metabolism and translation, including components of the small ribosomal subunit and multiple members of the RNA-processing hnRNP family. Interacting proteins were also in general co-expressed with MTHFD2 in experiments that stimulate or repress proliferation, suggesting a close functional relationship. Also, unlike other folate one-carbon enzymes, the MTHFD2 protein has a short half-life and responds rapidly to serum. Finally, shRNA against MTHFD2 depletes several of its interactors and yields an overall transcriptional response similar to targeted inhibition of certain ribosomal subunits.

Conclusions: Taken together, our findings suggest a novel function of MTHFD2 in RNA metabolism and translation.

Citing Articles

Proteomic and phosphoproteomic profilings reveal distinct cellular responses during entry and replication.

Lertwanakarn T, Khemthong M, Setthawong P, Phaonakrop N, Roytrakul S, Ploypetch S PeerJ. 2025; 13:e18923.

PMID: 39995988 PMC: 11849505. DOI: 10.7717/peerj.18923.


Nuclear localization of MTHFD2 is required for correct mitosis progression.

Pardo-Lorente N, Gkanogiannis A, Cozzuto L, Ganez Zapater A, Espinar L, Ghose R Nat Commun. 2024; 15(1):9529.

PMID: 39532843 PMC: 11557897. DOI: 10.1038/s41467-024-51847-z.


Selectivity analysis of diaminopyrimidine-based inhibitors of MTHFD1, MTHFD2 and MTHFD2L.

Jha V, Eriksson L Sci Rep. 2024; 14(1):21073.

PMID: 39256448 PMC: 11387627. DOI: 10.1038/s41598-024-71879-1.


The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation.

Marttila P, Bonagas N, Chalkiadaki C, Stigsdotter H, Schelzig K, Shen J Mol Oncol. 2024; 18(9):2179-2195.

PMID: 38533616 PMC: 11467796. DOI: 10.1002/1878-0261.13645.


SNHG3/hsa-miR-455-5p Axis-mediated High Expression of MTHFD2 Correlates with Tumor Immune Infiltration and Endometrial Carcinoma Progression.

Wu S, Cai W, Li Y, Tan W, Yuan Y, Zhou Z Int J Med Sci. 2023; 20(8):1097-1113.

PMID: 37484807 PMC: 10357439. DOI: 10.7150/ijms.81962.


References
1.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

2.
Zhu Q, Wong A, Krishnan A, Aure M, Tadych A, Zhang R . Targeted exploration and analysis of large cross-platform human transcriptomic compendia. Nat Methods. 2015; 12(3):211-4, 3 p following 214. PMC: 4768301. DOI: 10.1038/nmeth.3249. View

3.
Szklarczyk D, Morris J, Cook H, Kuhn M, Wyder S, Simonovic M . The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2016; 45(D1):D362-D368. PMC: 5210637. DOI: 10.1093/nar/gkw937. View

4.
Subramanian A, Narayan R, Corsello S, Peck D, Natoli T, Lu X . A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell. 2017; 171(6):1437-1452.e17. PMC: 5990023. DOI: 10.1016/j.cell.2017.10.049. View

5.
Koufaris C, Gallage S, Yang T, Lau C, Valbuena G, Keun H . Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion. J Proteome Res. 2016; 15(8):2618-25. DOI: 10.1021/acs.jproteome.6b00188. View